Search

Vongsavanh Sengdara

Examiner (ID: 14050, Phone: (571)270-5770 , Office: P/2829 )

Most Active Art Unit
2829
Art Unit(s)
4183, 2829, 2826, 2893
Total Applications
1059
Issued Applications
665
Pending Applications
170
Abandoned Applications
279

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8370181 [patent_doc_number] => 20120219564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'Human Antibodies That Bind Human TNFalpha' [patent_app_type] => utility [patent_app_number] => 13/466892 [patent_app_country] => US [patent_app_date] => 2012-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20857 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13466892 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/466892
Human antibodies that bind human TNFα May 7, 2012 Issued
Array ( [id] => 8689703 [patent_doc_number] => 08389228 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Process for the measurement of the potency of glatiramer acetate' [patent_app_type] => utility [patent_app_number] => 13/083112 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15049 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 272 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13083112 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/083112
Process for the measurement of the potency of glatiramer acetate Apr 7, 2011 Issued
Array ( [id] => 5944107 [patent_doc_number] => 20110104727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'ASSAYS FOR DIAGNOSING AND EVALUATING TREATMENT OPTIONS FOR FABRY DISEASE' [patent_app_type] => utility [patent_app_number] => 12/966904 [patent_app_country] => US [patent_app_date] => 2010-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13236 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104727.pdf [firstpage_image] =>[orig_patent_app_number] => 12966904 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/966904
ASSAYS FOR DIAGNOSING AND EVALUATING TREATMENT OPTIONS FOR FABRY DISEASE Dec 12, 2010 Abandoned
Array ( [id] => 6095329 [patent_doc_number] => 20110002935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'ANTIBODY PURIFICATION' [patent_app_type] => utility [patent_app_number] => 12/882601 [patent_app_country] => US [patent_app_date] => 2010-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 64062 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002935.pdf [firstpage_image] =>[orig_patent_app_number] => 12882601 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/882601
Purified antibody composition Sep 14, 2010 Issued
Array ( [id] => 6493210 [patent_doc_number] => 20100209409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'METHOD FOR SUPPRESSING IMMUNE SYSTEM RESPONSE TO TRANSPLANTED TISSUE OR CELLS' [patent_app_type] => utility [patent_app_number] => 12/773141 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8537 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209409.pdf [firstpage_image] =>[orig_patent_app_number] => 12773141 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/773141
Method for suppressing immune system response to transplanted tissue or cells May 3, 2010 Issued
Array ( [id] => 6520031 [patent_doc_number] => 20100261886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'PROTEIN PURIFICATION BY CITRATE PRECIPITATION' [patent_app_type] => utility [patent_app_number] => 12/759016 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8207 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261886.pdf [firstpage_image] =>[orig_patent_app_number] => 12759016 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/759016
Protein purification by citrate precipitation Apr 12, 2010 Issued
Array ( [id] => 6449960 [patent_doc_number] => 20100145029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'ENHANCED CAPACITY AND PURIFICATION OF ANTIBODIES BY MIXED MODE CHROMATOGRAPHY IN THE PRESENCE OF AQUEOUS-SOLUBLE NONIONIC ORGANIC POLYMERS' [patent_app_type] => utility [patent_app_number] => 12/709392 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6766 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20100145029.pdf [firstpage_image] =>[orig_patent_app_number] => 12709392 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/709392
Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers Feb 18, 2010 Issued
Array ( [id] => 8283047 [patent_doc_number] => 08217153 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Methods and systems for isolating target molecules from complex solutions by column-chromatography using wash solutions containing organic solvents' [patent_app_type] => utility [patent_app_number] => 12/693265 [patent_app_country] => US [patent_app_date] => 2010-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 3741 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12693265 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/693265
Methods and systems for isolating target molecules from complex solutions by column-chromatography using wash solutions containing organic solvents Jan 24, 2010 Issued
Array ( [id] => 4547562 [patent_doc_number] => 07820164 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Chimeric, human and humanized anti-CSAP monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 12/686011 [patent_app_country] => US [patent_app_date] => 2010-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 38238 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820164.pdf [firstpage_image] =>[orig_patent_app_number] => 12686011 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/686011
Chimeric, human and humanized anti-CSAP monoclonal antibodies Jan 11, 2010 Issued
Array ( [id] => 6339991 [patent_doc_number] => 20100247535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'Chemically Programmable Immunity' [patent_app_type] => utility [patent_app_number] => 12/685257 [patent_app_country] => US [patent_app_date] => 2010-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11398 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247535.pdf [firstpage_image] =>[orig_patent_app_number] => 12685257 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/685257
Chemically programmable immunity Jan 10, 2010 Issued
Array ( [id] => 6289406 [patent_doc_number] => 20100158803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies' [patent_app_type] => utility [patent_app_number] => 12/683538 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15871 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158803.pdf [firstpage_image] =>[orig_patent_app_number] => 12683538 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/683538
Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies Jan 6, 2010 Abandoned
Array ( [id] => 4612106 [patent_doc_number] => 07988951 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Method for inducing selectively suppressed immune response to transplanted tissue or cells' [patent_app_type] => utility [patent_app_number] => 12/627920 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8196 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/988/07988951.pdf [firstpage_image] =>[orig_patent_app_number] => 12627920 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/627920
Method for inducing selectively suppressed immune response to transplanted tissue or cells Nov 29, 2009 Issued
Array ( [id] => 7540564 [patent_doc_number] => 08058407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Purification of acidic proteins using ceramic hydroxyapatite chromatography' [patent_app_type] => utility [patent_app_number] => 12/608093 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7600 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/058/08058407.pdf [firstpage_image] =>[orig_patent_app_number] => 12608093 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/608093
Purification of acidic proteins using ceramic hydroxyapatite chromatography Oct 28, 2009 Issued
Array ( [id] => 4468905 [patent_doc_number] => 07943343 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'Production and use of novel peptide-based agents for use with bi-specific antibodies' [patent_app_type] => utility [patent_app_number] => 12/582009 [patent_app_country] => US [patent_app_date] => 2009-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16272 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943343.pdf [firstpage_image] =>[orig_patent_app_number] => 12582009 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/582009
Production and use of novel peptide-based agents for use with bi-specific antibodies Oct 19, 2009 Issued
Array ( [id] => 6467166 [patent_doc_number] => 20100040604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha' [patent_app_type] => utility [patent_app_number] => 12/578487 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25666 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040604.pdf [firstpage_image] =>[orig_patent_app_number] => 12578487 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/578487
Methods of treating disorders using human antibodies that bind human TNFα Oct 12, 2009 Issued
Array ( [id] => 6526868 [patent_doc_number] => 20100015055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'PRETREATMENT OF A BIOLOGICAL SAMPLE FROM AN AUTOIMMUNE DISEASE SUBJECT' [patent_app_type] => utility [patent_app_number] => 12/550729 [patent_app_country] => US [patent_app_date] => 2009-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 36084 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015055.pdf [firstpage_image] =>[orig_patent_app_number] => 12550729 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/550729
PRETREATMENT OF A BIOLOGICAL SAMPLE FROM AN AUTOIMMUNE DISEASE SUBJECT Aug 30, 2009 Abandoned
Array ( [id] => 6247285 [patent_doc_number] => 20100136624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method' [patent_app_type] => utility [patent_app_number] => 12/462189 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17558 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136624.pdf [firstpage_image] =>[orig_patent_app_number] => 12462189 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/462189
Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method Jul 29, 2009 Abandoned
Array ( [id] => 5472965 [patent_doc_number] => 20090246131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies' [patent_app_type] => utility [patent_app_number] => 12/481233 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16200 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246131.pdf [firstpage_image] =>[orig_patent_app_number] => 12481233 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/481233
Production and use of novel peptide-based agents for use with bi-specific antibodies Jun 8, 2009 Issued
Array ( [id] => 5398611 [patent_doc_number] => 20090318674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'PROCESS FOR PURIFICATION OF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/477031 [patent_app_country] => US [patent_app_date] => 2009-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18225 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318674.pdf [firstpage_image] =>[orig_patent_app_number] => 12477031 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/477031
PROCESS FOR PURIFICATION OF ANTIBODIES Jun 1, 2009 Abandoned
Array ( [id] => 6482040 [patent_doc_number] => 20100008855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'Production and Use of Novel Peptide-Based Agents with Bispecific Antibodies' [patent_app_type] => utility [patent_app_number] => 12/474665 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 40586 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008855.pdf [firstpage_image] =>[orig_patent_app_number] => 12474665 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/474665
Production and use of novel peptide-based agents with bispecific antibodies May 28, 2009 Issued
Menu